Safety and Efficacy of Inhaled Synthetic THC/CBD for Improving Physical Functioning and for Modulating Cachexia Progression in Patients With Advanced Cancer and Associated Cachexia

PHASE3SuspendedINTERVENTIONAL

Enrollment

334

Participants

Timeline

Start Date

July 31, 2022

Primary Completion Date

July 31, 2023

Study Completion Date

December 31, 2023

Conditions

Cannabis UseCachexia; CancerAdvanced Cancer

Interventions

DRUG

PPP011

1 capsule inhaled 3 times a day with a vaporizer device

DRUG

Placebo

1 capsule inhaled 3 times a day with a vaporizer device

Trial Locations (1)

William Osler Health Service Brampton, Brampton